Discovery20

Latest Headlines

Trending stories — sign in for a personalized feed

Today

Metallium Limited

Metallium Successfully Completes First 12-Hour Continuous Single Flash Joule Heating Reactor Run

a few seconds ago

Kura Oncology, Inc.

Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress

a minute ago

Skyward Specialty Insurance Group, Inc.

Skyward Specialty Appoints Melissa Goto to Lead E&S Brokerage and Inland Marine Businesses

2 minutes ago

Aquestive Therapeutics, Inc.

Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree

2 minutes ago

Geron Corporation

First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026

2 minutes ago

Agios Pharmaceuticals, Inc.

Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

2 minutes ago

Cogent Biosciences, Inc.

Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress

3 minutes ago

Beam Therapeutics Inc.

Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026

3 minutes ago

Caribou Biosciences, Inc.

Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting

3 minutes ago

Star Bulk Carriers Corp.

Star Bulk Announces Results of Its 2026 Annual Meeting of Shareholders

3 minutes ago

Agios Pharmaceuticals, Inc.

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

3 minutes ago

Appswarm, Inc.

AppSwarm Launches BARAI, Its AI-Powered App, on the Google Play Store

4 minutes ago

Moleculin Biotech, Inc.

Independent Cleveland Clinic Review Finds No Clinically Significant Cardiotoxicity with Moleculin's Annamycin in R/R AML Patients Dosed Beyond Conventional Anthracycline Limits

4 minutes ago

Incyte Corporation

Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress

4 minutes ago

Cellectis

Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress

5 minutes ago

Destination Xl Group, Inc.

Zodiac Partners II, LLC Launches a $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash

5 minutes ago

Londonmetric Property Plc

Form 8.3 - LondonMetric Property Plc & Schroder REIT

5 minutes ago

Pearl Diver Credit Company Inc.

Pearl Diver Credit Company Inc. Schedules First Quarter 2026 Earnings Release and Conference Call

22 minutes ago

Digital Brands Group, Inc.

Digital Brands Group Announces Guidance for Full-Year 2026 Revenue of $55 to $65 Million and Free Cash Flow of $2.5 to $3.5 Million

22 minutes ago

Globalstar, Inc.

Globalstar Announces Upcoming HIBLEO-4 Satellite Replenishment Launch with SpaceX

23 minutes ago

Published Apr 14 2026

5 min read

Manhattan Bridge Capital, Inc. Declares Quarterly Dividend

Name: 6ix Investment Platform
Brand: 6ix

GREAT NECK, N.Y., April 14, 2026 (GLOBE NEWSWIRE) --

Manhattan Bridge Capital, Inc. (NASDAQ: LOAN) announced today that its board of directors has declared a quarterly dividend of $0.11 per share to be paid to all shareholders of record on July 8, 2026. The dividend will be paid on July 15, 2026.

Contact:
Assaf Ran, CEO
(516) 444-3400
SOURCE: Manhattan Bridge Capital, Inc.